Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$1.75 - $8.19 $1.61 Million - $7.56 Million
-922,546 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$3.28 - $4.24 $784,933 - $1.01 Million
-239,309 Reduced 20.6%
922,546 $3.33 Million
Q1 2020

May 15, 2020

SELL
$3.96 - $8.37 $251,994 - $532,624
-63,635 Reduced 5.19%
1,161,855 $4.65 Million
Q3 2019

Nov 14, 2019

BUY
$4.02 - $7.93 $4.93 Million - $9.72 Million
1,225,490 New
1,225,490 $8.79 Million

Others Institutions Holding VCNX

About VACCINEX, INC.


  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $158M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Msd Partners, L.P. Portfolio

Follow Msd Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msd Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Msd Partners, L.P. with notifications on news.